Sigrid V. Carlsson, MD, PhD, MPH, presented “AI and Machine Learning: What the Future Holds” during the 27th Annual Southwest Prostate Cancer Symposium conference on October 17, 2024, in Scottsdale, Arizona.
How to cite: Carlsson, Sigrid V. “AI and Machine Learning: What the Future Holds.” October 17, 2024. Accessed Apr 2026. https://grandroundsinurology.com/ai-and-machine-learning-what-the-future-holds/
AI and Machine Learning: What the Future Holds – Summary
Sigrid V. Carlsson, MD, PhD, MPH, delves into the transformative potential of artificial intelligence (AI) and machine learning across various aspects of medicine and urology. She begins this 11-minute presentation by highlighting the broad applicability of large language models, such as ChatGPT, for tasks like scientific writing, coding, and summarizing articles. These tools prove particularly beneficial for non-native English speakers.
Dr. Carlsson emphasizes the importance of responsible AI use. Ethical concerns surrounding data privacy, plagiarism, and peer review confidentiality are discussed, underscoring the need for vigilance in scientific and clinical contexts.
Carlsson explores AI’s application in prostate MRI screening, pathology, and diagnostic accuracy. The technology is vital for standardizing care, addressing disparities, and enhancing health equity in underserved regions. Dr. Carlsson highlights the utility of AI in studying prostate cancer’s heterogeneous biology and touches on AI’s integration as a medical scribe, trial selection assistant, and simulator for surgical training.
About the 27th Annual Southwest Prostate Cancer Symposium:
Presented by Program Chairs Nelson N. Stone, MD, Richard G. Stock, MD, and William K. Oh, MD, this conference educated attendees about advances in the management of localized and advanced prostate cancer, with a focus on imaging, technology, and training in the related devices. It included a scientific session, as well as live demonstrations of surgical techniques. You can learn more about the conference here.
ABOUT THE AUTHOR
Sigrid V. Carlsson, MD, PhD, MPH, is the Division Head of the Clinical Epidemiology of Early Cancer Detection at DKFZ German Cancer Research Center in Heidelberg, Germany. Her research focuses on developing risk-stratified approaches to screening, diagnosis, treatment, and follow-up.
